Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand

Download the Quality Statements - published November 2021

The 'Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand' have been developed by the National Melanoma Working Group (NMWG), with support from the Melanoma Network of New Zealand (MelNet) and Te Aho o Te Kahu, the Cancer Control Agency. The statements describe what quality care for melanoma should look like in New Zealand and will inform efforts to reduce the incidence and improve outcomes for melanoma patients and their families. 

The document is an evolution of the Standards of Service Provision for Melanoma Patients in New Zealand – Provisional which were drafted by the National Melanoma Tumour Standards Working Group for the Ministry of Health in 2013. 

The 'Quality Statements' were formally launched at the New Zealand Melanoma Summit held virtually on 12 - 13 February 2022.

The document will be updated twice yearly to reflect the latest evidence, with the first review to be scheduled in the first half of 2022. 

The MelNet Executive Committee invite expressions of interest for representatives to join the National Melanoma Working Group responsible for reviewing and updating the 'Quality Statements'. If you are interested in being involved, please advise the MelNet Chief Executive